Entecavir hydrate cas no:209216-23-9
Synonyms: Baraclude;6H-Purin-6-one, 2-amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-, monohydrate;Intermediates of drug, pesticide and dye;Enticavir;Entecavir hydrate / 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate;Entecavir monohydrate;Entecavir API in stock;Entecavir(monohydrate)--Fine Product;
NameEntecavir hydrate
CAS209216-23-9
SynonymsBaraclude;6H-Purin-6-one, 2-amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-, monohydrate;Intermediates of drug, pesticide and dye;Enticavir;Entecavir hydrate / 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate;Entecavir monohydrate;Entecavir API in stock;Entecavir(monohydrate)--Fine Product;
Molecular FormulaC12H15N5O3.H2O
Molecular Weight295.3
AppearanceWhite crystalline powder
Safety
?Entecavir hydrate (CAS NO.209216-23-9) ?may cause lactic acidosis and severe hepatomegaly with steatosis (including fatal cases) when used alone or in combination with antiretrovirals. Severe acute hepatitis B exacerbations have occurred in patients who discontinued anti-hepatitis B therapy, including entecavir. Monitor hepatic function for at least several months after discontinuation. If appropriate, initiate anti-hepatitis B therapy.
